PLoS ONE
Home Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study
Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study
Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study

Article Type: Correction Article History
Table of Contents
The PLOS ONE Staff: Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study

There are errors in the images for Figs 15. The x-axis labels in Figs 1 and 2 and the legends in Figs 3 and 4 should be in English. The legend for Fig 5 is missing. Please see the correct Figs 15 here.

Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in different regions of Peru.
Fig 1

Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in different regions of Peru.

Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in urban and rural areas of Peru.
Fig 2

Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in urban and rural areas of Peru.

Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B).
Fig 3

Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B).

Prevalence of anti-HBc IgG after the implementation of the hepatitis B vaccination program in Peru.
Fig 4

Prevalence of anti-HBc IgG after the implementation of the hepatitis B vaccination program in Peru.

Prevalence of anti-HEV IgG in Peru, 2014–2015.
Fig 5

Prevalence of anti-HEV IgG in Peru, 2014–2015.

The publisher apologizes for the errors.

Reference

CCabezas, OTrujillo, ÁGonzales-Vivanco, CMBenites Villafane, JBalbuena, AOBorda-Olivas, et al. (2020) Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 15(6): e0234273. 10.1371/journal.pone.0234273